BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31782186)

  • 1. Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019.
    Nakamura Y; Asai J; Igaki H; Inozume T; Namikawa K; Hayashi A; Fukushima S; Fujimura T; Ito T; Imafuku K; Tanaka R; Teramoto Y; Minagawa A; Miyagawa T; Miyashita A; Wada M; Koga H; Sugaya M
    J Dermatol; 2020 Feb; 47(2):89-103. PubMed ID: 31782186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.
    Hoashi T; Ishikawa M; Uehara J; Oashi K; Maeda S; Kato J; Saruta H; Shichinohe R; Ohashi R; Nakamura Y; Koga H; Sugaya M;
    J Dermatol; 2024 Apr; 51(4):e90-e105. PubMed ID: 38264942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020.
    Ohtsuka M; Hamada T; Miyagaki T; Shimauchi T; Yonekura K; Kiyohara E; Fujita H; Izutsu K; Okuma K; Kawai K; Koga H; Sugaya M
    J Dermatol; 2021 Feb; 48(2):e49-e71. PubMed ID: 33245165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese Dermatological Association Guidelines: Outlines of Guidelines for Cutaneous Squamous Cell Carcinoma 2020.
    Ansai SI; Umebayashi Y; Katsumata N; Kato H; Kadono T; Takai T; Namiki T; Nakagawa M; Soejima T; Koga H; Sugaya M;
    J Dermatol; 2021 Jul; 48(7):e288-e311. PubMed ID: 33963604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
    Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
    J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma, version 2.2013: featured updates to the NCCN guidelines.
    Coit DG; Andtbacka R; Anker CJ; Bichakjian CK; Carson WE; Daud A; Dimaio D; Fleming MD; Guild V; Halpern AC; Hodi FS; Kelley MC; Khushalani NI; Kudchadkar RR; Lange JR; Lind A; Martini MC; Olszanski AJ; Pruitt SK; Ross MI; Swetter SM; Tanabe KK; Thompson JA; Trisal V; Urist MM; McMillian N; Ho M;
    J Natl Compr Canc Netw; 2013 Apr; 11(4):395-407. PubMed ID: 23584343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Dummer R; Hauschild A; Pentheroudakis G
    Ann Oncol; 2009 May; 20 Suppl 4():129-31. PubMed ID: 19454433
    [No Abstract]   [Full Text] [Related]  

  • 10. Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels.
    Kroon BB; Nieweg OE; Hoekstra HJ; Lejeune FJ
    Eur J Surg Oncol; 1997 Dec; 23(6):550-8. PubMed ID: 9484929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.
    Castro LG; Messina MC; Loureiro W; Macarenco RS; Duprat Neto JP; Di Giacomo TH; Bittencourt FV; Bakos RM; Serpa SS; Stolf HO; Gontijo G
    An Bras Dermatol; 2015; 90(6):851-61. PubMed ID: 26734867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK guidelines for the management of cutaneous melanoma.
    Bishop JA; Corrie PG; Evans J; Gore ME; Hall PN; Kirkham N; Roberts DL; Anstey AV; Barlow RJ; Cox NH; ;
    Br J Plast Surg; 2002 Jan; 55(1):46-54. PubMed ID: 11783968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstacles to improving outcomes in the treatment of uveal melanoma.
    Tsai KK; Bollin KB; Patel SP
    Cancer; 2018 Jul; 124(13):2693-2703. PubMed ID: 29579316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.K. guidelines for the management of cutaneous melanoma.
    Roberts DL; Anstey AV; Barlow RJ; Cox NH; Newton Bishop JA; Corrie PG; Evans J; Gore ME; Hall PN; Kirkham N; ;
    Br J Dermatol; 2002 Jan; 146(1):7-17. PubMed ID: 11841361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.
    Sugaya M; Hamada T; Kawai K; Yonekura K; Ohtsuka M; Shimauchi T; Tokura Y; Nozaki K; Izutsu K; Suzuki R; Setoyama M; Nagatani T; Koga H; Tani M; Iwatsuki K
    J Dermatol; 2013 Jan; 40(1):2-14. PubMed ID: 22900999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
    Akamatsu H; Ninomiya K; Kenmotsu H; Morise M; Daga H; Goto Y; Kozuki T; Miura S; Sasaki T; Tamiya A; Teraoka S; Tsubata Y; Yoshioka H; Hattori Y; Imamura CK; Katsuya Y; Matsui R; Minegishi Y; Mizugaki H; Nosaki K; Okuma Y; Sakamoto S; Sone T; Tanaka K; Umemura S; Yamanaka T; Amano S; Hasegawa K; Morita S; Nakajima K; Maemondo M; Seto T; Yamamoto N
    Int J Clin Oncol; 2019 Jul; 24(7):731-770. PubMed ID: 31049758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEOM clinical guideline for the management of cutaneous melanoma (2020).
    Majem M; Manzano JL; Marquez-Rodas I; Mujika K; Muñoz-Couselo E; Pérez-Ruiz E; de la Cruz-Merino L; Espinosa E; Gonzalez-Cao M; Berrocal A
    Clin Transl Oncol; 2021 May; 23(5):948-960. PubMed ID: 33651321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94].
    Orfanos CE; Jung EG; Rassner G; Wolff HH; Garbe C
    Hautarzt; 1994 May; 45(5):285-91. PubMed ID: 8050898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
    Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.